Sunshine Act Meeting, 38713-38714 [2021-15734]

Download as PDF Federal Register / Vol. 86, No. 138 / Thursday, July 22, 2021 / Notices ENVIRONMENTAL PROTECTION AGENCY [FRL–8712–01–R6] Protection Agency, Region 6, Drinking Water Section (6WD–DD), 1201 Elm St, Dallas, TX 75270. FEDERAL DEPOSIT INSURANCE CORPORATION Jose´ G. Rodriguez, EPA Region 6, Drinking Water Section at the Dallas address given above, or by telephone at (214) 665–8087, or by email at rodriguez.jose@epa.gov. Authority: Section 1413 of the Safe Drinking Water Act, as amended (1996), and 40 CFR part 142 of the National Primary Drinking Water Regulations. Sunshine Act Meeting FOR FURTHER INFORMATION CONTACT: Public Water System Supervision Program Revision for the State of Texas Environmental Protection Agency (EPA). ACTION: Notice of tentative approval. AGENCY: Notice is hereby given that the State of Texas is revising its approved Public Water System Supervision (PWSS) program. Texas has adopted the Environmental Protection Agency (EPA) drinking water rule for Variance and Exemptions (V&E). EPA has determined that the proposed V&E Rule submitted by Texas is no less stringent than the corresponding federal regulations. Therefore, EPA intends to approve this PWSS program revision package. SUMMARY: All interested parties may request a public hearing. A request for a public hearing must be submitted by August 23, 2021 to the Regional Administrator at the EPA Region 6 address shown below. Frivolous or insubstantial requests for a hearing may be denied by the Regional Administrator. However, if a substantial request for a public hearing is made by August 23, 2021, a public hearing will be held. If no timely and appropriate request for a hearing is received and the Regional Administrator does not elect to hold a hearing on his own motion, this determination shall become final and effective on August 23, 2021. Any request for a public hearing shall include the following information: The name, address, and telephone number of the individual, organization, or other entity requesting a hearing; a brief statement of the requesting person’s interest in the Regional Administrator’s determination and a brief statement of the information that the requesting person intends to submit at such hearing; and the signature of the individual making the request, or, if the request is made on behalf of an organization or other entity, the signature of a responsible official of the organization or other entity. ADDRESSES: All documents relating to this determination are available for inspection between the hours of 8:00 a.m. and 4:30 p.m., Monday through Friday, at the following offices: Texas Commission on Environmental Quality, Water Supply Division, Public Drinking Water Section (MC–155), Building F, 12100 Park 35 Circle, Austin, TX 78753; and United States Environmental lotter on DSK11XQN23PROD with NOTICES1 DATES: VerDate Sep<11>2014 17:10 Jul 21, 2021 Jkt 253001 38713 Dated: July 9, 2021. David Gray, Acting Regional Administrator, Region 6. [FR Doc. 2021–15470 Filed 7–21–21; 8:45 am] BILLING CODE 6560–50–P FEDERAL DEPOSIT INSURANCE CORPORATION Sunshine Act Meetings; Notice of a Matter To Be Deferred From the Agenda for Consideration at an Agency Meeting FEDERAL REGISTER CITATION OF PREVIOUS ANNOUNCEMENT: The previously announced meeting agenda of the Board of Directors, published at 86 FR 37752, has changed. PREVIOUSLY ANNOUNCED TIME AND DATE OF THE MEETING: Tuesday, July 20, 2021, at 10:00 a.m. Pursuant to the provisions of the ‘‘Government in the Sunshine Act’’ (5 U.S.C. 552b), notice is hereby given that the following matter will be deferred from the Summary Agenda at the open meeting of the Board of Directors of the Federal Deposit Insurance Corporation scheduled to be held at 10:00 a.m. on July 20, 2021, via a Webcast live on the internet: Memorandum and resolution re: Notice of Proposed Rulemaking on Revisions to Standardized Approach for Calculating the Exposure Amount of Derivative Contracts. CHANGES IN THE MEETING: CONTACT PERSON FOR MORE INFORMATION: Requests for further information concerning the meeting may be directed to Debra A. Decker, Deputy Executive Secretary of the Corporation, at (202) 898–8748. Federal Deposit Insurance Corporation. Dated at Washington, DC, on July 19, 2021. James P. Sheesley, Assistant Executive Secretary. [FR Doc. 2021–15672 Filed 7–20–21; 11:15 am] BILLING CODE 6714–01–P PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 10:17 a.m. on Tuesday, July 20, 2021. PLACE: The meeting was held via video conference on the internet. STATUS: Closed. MATTERS TO BE CONSIDERED: In calling the meeting, the Board determined, on motion of Director Martin J. Gruenberg, seconded by Director Michael J. Hsu (Acting Comptroller of the Currency), and concurred in by Director David Uejio (Acting Director, Consumer Financial Protection Bureau), and Chairman Jelena McWilliams, that Corporation business required its consideration of the matters which were to be the subject of this meeting on less than seven days’ notice to the public; that no earlier notice of the meeting was practicable; that the public interest did not require consideration of the matters in a meeting open to public observation; and that the matters could be considered in a closed meeting by authority of subsections (c)(4), (c)(6), (c)(8), (c)(9)(A)(ii), and (c)(9)(B) of the ‘‘Government in the Sunshine Act’’ (5 U.S.C. 552b(c)(4), (c)(6), (c)(8), (c)(9)(A)(ii), and (c)(9)(B). CONTACT PERSON FOR MORE INFORMATION: Requests for further information concerning the meeting may be directed to Debra A. Decker, Deputy Executive Secretary of the Corporation, at 202– 898–8748. TIME AND DATE: Dated this the 20th day of July, 2021. Federal Deposit Insurance Corporation. James P. Sheesley, Assistant Executive Secretary. [FR Doc. 2021–15729 Filed 7–20–21; 4:15 pm] BILLING CODE 6714–01–P FEDERAL ELECTION COMMISSION Sunshine Act Meeting Tuesday, July 27, 2021 at 10:00 a.m. and its continuation at the conclusion of the open meeting on July 29, 2021. PLACE: 1050 First Street NE, Washington, DC (This meeting will be a virtual meeting). STATUS: This meeting will be closed to the public. MATTERS TO BE CONSIDERED: Compliance matters pursuant to 52 U.S.C. § 30109. Matters concerning participation in civil actions or proceedings or arbitration. * * * * * TIME AND DATE: E:\FR\FM\22JYN1.SGM 22JYN1 38714 Federal Register / Vol. 86, No. 138 / Thursday, July 22, 2021 / Notices CONTACT PERSON FOR MORE INFORMATION: Judith Ingram, Press Officer. Telephone: (202) 694–1220. Vicktoria J. Allen, Acting Deputy Secretary of the Commission. [FR Doc. 2021–15734 Filed 7–20–21; 4:15 pm] Board of Governors of the Federal Reserve System, July 19, 2021. Michele Taylor Fennell, Deputy Associate Secretary of the Board. [FR Doc. 2021–15593 Filed 7–21–21; 8:45 am] BILLING CODE P BILLING CODE 6715–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES FEDERAL RESERVE SYSTEM Agency for Healthcare Research and Quality lotter on DSK11XQN23PROD with NOTICES1 Change in Bank Control Notices; Acquisitions of Shares of a Bank or Bank Holding Company The notificants listed below have applied under the Change in Bank Control Act (Act) (12 U.S.C. 1817(j)) and § 225.41 of the Board’s Regulation Y (12 CFR 225.41) to acquire shares of a bank or bank holding company. The factors that are considered in acting on the applications are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)). The public portions of the applications listed below, as well as other related filings required by the Board, if any, are available for immediate inspection at the Federal Reserve Bank(s) indicated below and at the offices of the Board of Governors. This information may also be obtained on an expedited basis, upon request, by contacting the appropriate Federal Reserve Bank and from the Board’s Freedom of Information Office at https://www.federalreserve.gov/foia/ request.htm. Interested persons may express their views in writing on the standards enumerated in paragraph 7 of the Act. Comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors, Ann E. Misback, Secretary of the Board, 20th Street and Constitution Avenue NW, Washington, DC 20551–0001, not later than August 6, 2021. A. Federal Reserve Bank of Dallas (Karen Smith, Director, Applications) 2200 North Pearl Street, Dallas, Texas 75201–2272: 1. The Vanguard Group, Inc., Malvern, Pennsylvania; on behalf of itself, its subsidiaries and affiliates, including investment companies registered under the Investment Company Act of 1940, other pooled investment vehicles, and institutional accounts that are sponsored, managed, or advised by Vanguard; to acquire additional voting shares of Comerica Incorporated, Dallas, Texas, and thereby indirectly acquire additional voting shares of Comerica Bank, Dallas, Texas, and Comerica Bank & Trust, National Association, Ann Arbor, Michigan. VerDate Sep<11>2014 17:10 Jul 21, 2021 Jkt 253001 Agency Information Collection Activities: Proposed Collection; Comment Request Agency for Healthcare Research and Quality (AHRQ), HHS. ACTION: Notice. AGENCY: This notice announces the intention of the Agency for Healthcare Research and Quality (AHRQ) to request that the Office of Management and Budget (OMB) approve the proposed information collection project: ‘‘The AHRQ Safety Program for MethicillinResistant Staphylococcus aureus (MRSA) Prevention.’’ This proposed information collection was previously published in the Federal Register on May 3rd, 2021 and allowed 60 days for public comment. AHRQ did not receive any substantive comments from members of the public. The purpose of this notice is to allow an additional 30 days for public comment. DATES: Comments on this notice must be received by August 23, 2021. ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain . Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. FOR FURTHER INFORMATION CONTACT: Doris Lefkowitz, AHRQ Reports Clearance Officer, (301) 427–1477, or by email at doris.lefkowitz@AHRQ.hhs.gov. SUPPLEMENTARY INFORMATION: SUMMARY: Proposed Project The AHRQ Safety Program for Methicillin-Resistant Staphylococcus aureus (MRSA) Prevention As part of the HHS HAI National Action Plan (NAP), AHRQ has supported the implementation and adoption of the Comprehensive Unitbased Safety Program (CUSP) to reduce Central-Line Associated Bloodstream Infections (CLABSI) and Catheter- PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 Associated Urinary Tract Infections (CAUTI), and subsequently applied CUSP to other clinical challenges, including reducing surgical site infections and improving care for mechanically ventilated patients. As part of the National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB NAP), the HHS HAI National Action Plan, and Healthy People 2030 goals, AHRQ will now apply the principles and concepts that have been learned from these HAI reduction efforts to the prevention of MRSA invasive infections. Healthcare-associated infections, or HAIs, are a highly significant cause of illness and death for patients in the U.S. At any given time, HAIs affect one out of every 31 hospital inpatients. More than a million of these infections occur across our health care system every year. This leads to significant patient harm and loss of life, and costs billions of dollars each year in medical and nonmedical costs. In addition, the 3 million Americans currently residing in U.S. nursing homes experience a staggering 2–3 million HAIs each year. Particular concern has arisen related to the persistent prevalence of methicillin-resistant Staphylococcus aureus (MRSA). This bacterium affects both communities and healthcare facilities, but the majority of morbidity and mortality occurs in critically and chronically ill patients. While MRSA was rare in the US through the 1970s, its prevalence in US health care facilities began rising in the 1980s and has continued to do so. In 2000, MRSA was responsible for 133,510 hospitalizations in children and adults. This number more than doubled by 2005, with 278,203 hospitalizations along with 56,248 septic events and 6,639 deaths being attributed to MRSA. MRSA has become a major form of hospital-associated Staphylococcus aureus infection. For various patient safety initiatives, AHRQ has promoted the implementation and adoption of the Comprehensive Unit-based Safety Program (CUSP) approach which combines clinical and cultural (i.e., technical and adaptive) intervention components to facilitate the implementation of technical bundles to improve patient safety. For MRSA prevention, it is likely that a combination of technical approaches is indicated, including decolonization along with classic infection control practices such as hand hygiene, environmental cleaning, general HAI prevention, and contact precautions/ isolation. Implementation of these technical approaches would benefit E:\FR\FM\22JYN1.SGM 22JYN1

Agencies

[Federal Register Volume 86, Number 138 (Thursday, July 22, 2021)]
[Notices]
[Pages 38713-38714]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-15734]


=======================================================================
-----------------------------------------------------------------------

FEDERAL ELECTION COMMISSION


Sunshine Act Meeting

TIME AND DATE: Tuesday, July 27, 2021 at 10:00 a.m. and its 
continuation at the conclusion of the open meeting on July 29, 2021.

PLACE:  1050 First Street NE, Washington, DC (This meeting will be a 
virtual meeting).

STATUS: This meeting will be closed to the public.

MATTERS TO BE CONSIDERED: Compliance matters pursuant to 52 U.S.C. 
Sec.  30109.
    Matters concerning participation in civil actions or proceedings or 
arbitration.
* * * * *

[[Page 38714]]


CONTACT PERSON FOR MORE INFORMATION: Judith Ingram, Press Officer. 
Telephone: (202) 694-1220.

Vicktoria J. Allen,
Acting Deputy Secretary of the Commission.
[FR Doc. 2021-15734 Filed 7-20-21; 4:15 pm]
BILLING CODE 6715-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.